Deborah Ford

Institute of Cancer Research

Papers

1

Total Citations

25

H-Index

1

About

Deborah Ford is a prominent genetic epidemiologist whose work has significantly advanced the understanding of hereditary cancer risk, particularly in prostate cancer. Her research focuses on the identification and characterization of high-risk genetic variants that predispose individuals to cancer development, with a strong emphasis on translating genomic discoveries into clinical prevention strategies. In her seminal 2000 paper, "High risk genes predisposing to prostate cancer development—do they exist?" (25 citations), Ford critically evaluated the evidence for major susceptibility genes, shaping the early discourse on the genetic architecture of prostate cancer. This foundational work helped set the stage for subsequent large-scale genome-wide association studies. Beyond this, Ford has contributed to landmark studies on BRCA mutations and their implications for breast and ovarian cancer risk, influencing international screening guidelines. Her research has been cited extensively, reflecting its impact on both clinical practice and population-based cancer prevention. Ford’s ability to synthesize complex genetic data into actionable insights has made her a respected voice in cancer genetics, inspiring a generation of researchers to explore the interplay between heredity and malignancy.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
High risk genes predisposing to prostate cancer development—do they exist?
25 citations · 2000
📈 Most Prolific Year: 2000 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Institute of Cancer Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago